Eagle Pharmaceuticals: Q4 Earnings Insights


Eagle Pharmaceuticals EGRX reported its Q4 earnings results on Monday, March 7, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.


Eagle Pharmaceuticals missed estimated earnings by 9.57%, reporting an EPS of $0.85 versus an estimate of $0.94.

Revenue was down $7.60 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 0.6% increase in the share price the next day.

Here's a look at Eagle Pharmaceuticals's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.83 0.80 0.65 -0.17
EPS Actual 0.56 0.93 0.24 0.96
Revenue Estimate 46.40M 45.86M 45.41M 53.16M
Revenue Actual 39.85M 48.12M 41.25M 49.92M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!